Find and Pitch Jounalists, Get Your Story Covered

Tags: hemophilia A bleeding hemophilia antithrombin clotting factor

	Profile	Recent Articles on Subject
1	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Fitusiran Approved for Hemophilia A and B - 20 days ago Transitioning From Pediatric to Adult Care for Beta-Thalassemia - 4 months ago Stem Cell Transplantation Still the Main Treatment Option for Beta-Thalassemia - 4 months ago Gene Therapy for Hemophilia Becomes a Reality - over 1 year ago Novel Monoclonal Antibody Reduces Bleeds in Hemophilia A and B - over 1 year ago Emicizumab Safe, Effective, in Infants With Hemophilia A - over 1 year ago Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL - over 1 year ago First Treatment Approved for Genetic Clotting Disorder - over 1 year ago Emicizumab Can Delay Immunosuppressive Tx in Acquired Hemophilia A - over 1 year ago
2	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	Encouraging DOAC Data for Afib With Various Valvular Heart Diseases - 2 months ago Preeclampsia Blood Marker? Pediatric Cardiac Doc Arrested; Afib-Detecting Ring - 9 months ago A More Selective Enoxaparin Thromboprophylaxis Protocol May Be Safer for New Moms - 10 months ago FXI Inhibitor Cuts Bleeds in Afib; COAPT Extends to Real World; AI Stroke Triage - over 1 year ago
3	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Andembry treatment approved across Europe - 2 months ago Hemgenix shows efficacy among haemophilia B patients - 2 months ago
4	Emily Cooke Live Science Health reporter. London, United Kingdom healthscience	People with this rare genetic condition can't repair damage to their DNA - 2 months ago
5	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Pfizer Ends Sangamo Alliance With Gene Therapy for Hemophilia on Cusp of FDA Filing - 4 months ago Novo Nordisk Adds to Manufacturing Capacity, Pumping Billions Into New Rare Disease Site - 4 months ago Pfizer Hemophilia Gene Therapy Meets Phase 3 Goals, But Its Success Matters More to Sangamo - 9 months ago
6	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: Pfizer kills hemophilia gene therapy deal, imperiling Sangamo - 4 months ago STAT+: Pfizer gene therapy reduced hemophilia bleeds, but questions remain - 9 months ago STAT+: Hemophilia gene therapies arrived after 40 years of struggle. Where are the patients? - about 1 year ago
7	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	Sanofi advances a drug for a rare, platelet-destroying disease - 4 months ago
8	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	Sanofi advances a drug for a rare, platelet-destroying disease - 4 months ago
9	Hannah Thomasy, PhD The Scientist Freelance science writer. PhD. Seattle & Toronto ScienceFreelance Writing	Why Do People Have Different Blood Types? - 7 months ago
10	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Grants 510(k) Clearance for Traumagel to Control Bleeding - 8 months ago FDA Extends Approval of Fibryga to Include Bleeding Patients With Acquired Fibrinogen Deficiency - 9 months ago Study: Mim8 Shows Reductions in Treated Bleeds for Patients With Hemophilia A - 10 months ago Luspatercept Reduces Transfusion Burden Compared With Epoetin Alfa - 10 months ago FDA Accepts Supplemental Biologics License Application of Altuviiio for Children With Severe Hemophilia A - over 1 year ago

Journalists covering hemophilia